Navigation Links
NutraCea Appoints New Chief Financial Officer
Date:11/6/2008

PHOENIX, Nov. 6 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB), nutrient research and technology announced today that it has appointed Olga Hernandez-Longan [45] to the position of Chief Financial Officer. Todd Crow, in accordance with his previously announced intentions, has retired as CFO, but will remain available in a consulting and advisory capacity.

Ms. Hernandez-Longan has over 20 years of financial experience in working with both public and private corporations in financial planning and analysis, SEC reporting, international finance, corporate M&A, divestitures and joint ventures.

She served as Vice President and Controller of Wal-Mart International from 2004 until 2006 with responsibility for finance, accounting, Sarbanes-Oxley 404 Compliance, and internal and external reporting. In her position she worked closely with the company's strategy group on financial direction for potential acquisitions/joint ventures and on integration of acquisitions within Wal-Mart International. Ms. Hernandez-Longan was also a member of Wal- Mart's Disclosure Committee.

Prior to joining Wal-Mart, she spent nearly four years at Ford Motor Company, rising from Controller of Vehicle Procurement Operations to Chief Financial Officer of Ford of Brazil, where she had responsibility for finance, accounting and treasury and while there successfully restructured the existing business. This restructuring resulted in significant sustained fixed cost improvements, enhanced revenue, improved cash management and bottom-line profitability. Upon returning to North America, Ms. Hernandez-Longan was appointed Controller of Ford's Customer Service Division North American Operations.

Prior to Ford, she was with Eaton Corporation where she served as Chief Financial Officer and Worldwide Controller of the company's Automotive Controls Operations. Responsibilities included in depth strategic business analysis, monthly forecasting, strategic/annual profit plans and Information Technology. She helped sell the Vehicle Switch Division to Delphi in late 2000 and restructured Automotive Controls for improved profitability.

Most recently, and prior to joining NutraCea, Hernandez-Longan was a Partner with Tatum LLC in their Financial Executive Practice. There she served as Interim Chief Financial Officer of companies such as Wells Dairy, makers of Blue Bunny Brand ice cream and Terlato Wine Group, a luxury wine producer and distributor where she had responsibility for all accounting, financial planning and M&A/joint venture activity.

Brad Edson, President and Chief Executive Officer of NutraCea commented, "We are extremely pleased to have Olga join our management team. Her expertise in financial reporting, international finance and M&A and joint ventures will serve NutraCea well as we continue to implement our strategic growth plan."

About NutraCea

NutraCea is a world leader in production and utilization of stabilized rice bran. They hold many patents for stabilized rice bran production technology and proprietary neutraceutical formulas ranging from arthritis, chronic bowel conditions, and effective diabetes control to cardiovascular disease treatment protocols. NutraCea's proprietary technology enables the creation of food and nutrition products to be unlocked from rice bran, normally a waste by-product of standard rice processing. Committed to helping the under fed, they're heavily involved in providing product and technology for developing countries through NutraCea's RiceAde feeding program. More information can be found in the Company's filings with the SEC and you can visit the NutraCea web site http://www.NutraCea.com.


'/>"/>
SOURCE NutraCea
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... MANHASSET, N.Y. , Jan. 16, 2017   ... Kevin J. Tracey, MD , president and CEO of ... Northwell Health, completed an analysis of how the nervous ... further identify and develop bioelectronic medicine devices ... today in Nature Neuroscience . The ...
(Date:1/16/2017)... Ky. , Jan. 16, 2017  Eurofins Genomics ... which will allow more customers to receive their primers ... premium or compromise in quality found with other providers. ... the United States at no additional fee. ... of routine genetic studies, including DNA sequencing, genotyping, site-directed ...
(Date:1/14/2017)...  The Alliance for Safe Biologic Medicines (ASBM) today ... final guidance on biologic naming: We ... the importance of distinct naming for all biologics, including ... biosimilars will bring to patients, including new treatment options ... of the Guidance dealing with suffix design remains at ...
(Date:1/13/2017)... Research and Markets has announced the addition of ... ... grow at a CAGR of 16.83% during the period 2017-2021. ... the global biopolymers market for 2017-2021. To calculate the market size, the ... products. The report also includes a a discussion of the key vendors ...
Breaking Biology Technology:
(Date:12/7/2016)... 2016 BioCatch , the global leader in ... portfolio, which grew to over 40 granted and pending patents. ... , , The ... " System, Device, and Method Estimating Force Applied to a ... to forego costly hardware components needed to estimate the force and pressure ...
(Date:12/6/2016)... 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... offering of €500.0 million principal amount of its 1.414% senior ... its 2.425% senior unsecured notes due 2026. ... December 13, 2016, subject to the satisfaction of customary closing conditions.  ... The Company intends to use the ...
(Date:12/5/2016)... WASHINGTON , Dec. 5, 2016  The ... (NIJ), today published "Can CT Scans Enhance or ... examines the potential of supporting or replacing forensic ... a CT scan. In response to ... NIJ is exploring using CT scans as a ...
Breaking Biology News(10 mins):